PortfoliosLab logo
FPHAX vs. FSMEX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FPHAX and FSMEX is 0.70, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.0
Correlation: 0.7

Performance

FPHAX vs. FSMEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). The values are adjusted to include any dividend payments, if applicable.

400.00%500.00%600.00%700.00%800.00%December2025FebruaryMarchAprilMay
450.64%
669.10%
FPHAX
FSMEX

Key characteristics

Sharpe Ratio

FPHAX:

-0.49

FSMEX:

-0.31

Sortino Ratio

FPHAX:

-0.54

FSMEX:

-0.29

Omega Ratio

FPHAX:

0.93

FSMEX:

0.96

Calmar Ratio

FPHAX:

-0.34

FSMEX:

-0.17

Martin Ratio

FPHAX:

-0.78

FSMEX:

-0.91

Ulcer Index

FPHAX:

12.85%

FSMEX:

7.17%

Daily Std Dev

FPHAX:

20.53%

FSMEX:

20.84%

Max Drawdown

FPHAX:

-37.34%

FSMEX:

-43.45%

Current Drawdown

FPHAX:

-22.04%

FSMEX:

-33.77%

Returns By Period

In the year-to-date period, FPHAX achieves a -3.86% return, which is significantly higher than FSMEX's -4.86% return. Over the past 10 years, FPHAX has underperformed FSMEX with an annualized return of 1.50%, while FSMEX has yielded a comparatively higher 4.52% annualized return.


FPHAX

YTD

-3.86%

1M

5.36%

6M

-11.82%

1Y

-9.35%

5Y*

2.08%

10Y*

1.50%

FSMEX

YTD

-4.86%

1M

6.44%

6M

-11.61%

1Y

-7.47%

5Y*

0.34%

10Y*

4.52%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FPHAX vs. FSMEX - Expense Ratio Comparison

FPHAX has a 0.75% expense ratio, which is higher than FSMEX's 0.68% expense ratio.


Expense ratio chart for FPHAX: current value is 0.75%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
FPHAX: 0.75%
Expense ratio chart for FSMEX: current value is 0.68%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
FSMEX: 0.68%

Risk-Adjusted Performance

FPHAX vs. FSMEX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FPHAX
The Risk-Adjusted Performance Rank of FPHAX is 33
Overall Rank
The Sharpe Ratio Rank of FPHAX is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of FPHAX is 22
Sortino Ratio Rank
The Omega Ratio Rank of FPHAX is 33
Omega Ratio Rank
The Calmar Ratio Rank of FPHAX is 22
Calmar Ratio Rank
The Martin Ratio Rank of FPHAX is 44
Martin Ratio Rank

FSMEX
The Risk-Adjusted Performance Rank of FSMEX is 55
Overall Rank
The Sharpe Ratio Rank of FSMEX is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of FSMEX is 55
Sortino Ratio Rank
The Omega Ratio Rank of FSMEX is 66
Omega Ratio Rank
The Calmar Ratio Rank of FSMEX is 66
Calmar Ratio Rank
The Martin Ratio Rank of FSMEX is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FPHAX vs. FSMEX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for FPHAX, currently valued at -0.49, compared to the broader market-1.000.001.002.003.00
FPHAX: -0.49
FSMEX: -0.31
The chart of Sortino ratio for FPHAX, currently valued at -0.54, compared to the broader market-2.000.002.004.006.008.00
FPHAX: -0.54
FSMEX: -0.29
The chart of Omega ratio for FPHAX, currently valued at 0.93, compared to the broader market0.501.001.502.002.503.00
FPHAX: 0.93
FSMEX: 0.96
The chart of Calmar ratio for FPHAX, currently valued at -0.34, compared to the broader market0.002.004.006.008.0010.00
FPHAX: -0.34
FSMEX: -0.17
The chart of Martin ratio for FPHAX, currently valued at -0.78, compared to the broader market0.0010.0020.0030.0040.00
FPHAX: -0.78
FSMEX: -0.91

The current FPHAX Sharpe Ratio is -0.49, which is lower than the FSMEX Sharpe Ratio of -0.31. The chart below compares the historical Sharpe Ratios of FPHAX and FSMEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50December2025FebruaryMarchAprilMay
-0.49
-0.31
FPHAX
FSMEX

Dividends

FPHAX vs. FSMEX - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 1.38%, while FSMEX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
FPHAX
Fidelity Select Pharmaceuticals Portfolio
1.38%1.21%0.63%1.33%1.17%1.31%1.31%1.44%1.33%1.07%5.59%5.81%
FSMEX
Fidelity Select Medical Technology and Devices Portfolio
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%11.71%5.17%

Drawdowns

FPHAX vs. FSMEX - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -37.34%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FPHAX and FSMEX. For additional features, visit the drawdowns tool.


-40.00%-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%December2025FebruaryMarchAprilMay
-22.04%
-33.77%
FPHAX
FSMEX

Volatility

FPHAX vs. FSMEX - Volatility Comparison

The current volatility for Fidelity Select Pharmaceuticals Portfolio (FPHAX) is 11.90%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 12.57%. This indicates that FPHAX experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%December2025FebruaryMarchAprilMay
11.90%
12.57%
FPHAX
FSMEX